These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26598562)
1. Ectopic Schistosoma mansoni Eggs Inside a Lipoma. Sabino KR; Nunes MB; Petroianu A Am J Trop Med Hyg; 2016 Jan; 94(1):156-7. PubMed ID: 26598562 [TBL] [Abstract][Full Text] [Related]
2. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine. Conceição MJ; Argento CA; Corrêa A Mem Inst Oswaldo Cruz; 2000; 95(3):375-80. PubMed ID: 10800196 [TBL] [Abstract][Full Text] [Related]
3. Pseudoneoplastic lesion of the breast caused by Schistosoma mansoni. Lima CA; Cavalcanti AC; Lima MM; Piva N Rev Soc Bras Med Trop; 2004; 37(1):63-4. PubMed ID: 15042188 [TBL] [Abstract][Full Text] [Related]
4. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm. Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515 [TBL] [Abstract][Full Text] [Related]
6. [On the reversal of schistosomiasis hepatic fibrosis after specific therapy. Histopathologic study]. Chapadeiro E; Pitanga LC Rev Soc Bras Med Trop; 1997; 30(1):53-6. PubMed ID: 9026832 [TBL] [Abstract][Full Text] [Related]
7. [Schistosomiasis mansoni simulating bladder neoplasia]. Lopes EJ; dos Santos TC; Martins V Rev Soc Bras Med Trop; 2006; 39(3):287-8. PubMed ID: 16906256 [TBL] [Abstract][Full Text] [Related]
8. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni. Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757 [TBL] [Abstract][Full Text] [Related]
9. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase. Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366 [No Abstract] [Full Text] [Related]
10. Schistosomiasis mansoni of the bladder simulating bladder cancer: a case report. Casella ML; Fanni VS; Verndl DO; Basso MC; Mello LF; Glina S Rev Soc Bras Med Trop; 2009; 42(5):581-2. PubMed ID: 19967243 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia. Al-Aska AK Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212 [TBL] [Abstract][Full Text] [Related]
12. Treatment of schistosomiasis: gathering stones together. Lambertucci JR Mem Inst Oswaldo Cruz; 1995; 90(2):161-4. PubMed ID: 8531651 [No Abstract] [Full Text] [Related]
13. Treatment of human acute schistosomiasis with oxamniquine induces an increase in interferon-gamma response to Schistosoma mansoni antigens. de Souza JR; Morais CN; Aroucha ML; Miranda PJ; Barbosa CS; Domingues AL; Carvalho Júnior LB; Abath FG; Montenegro SM Mem Inst Oswaldo Cruz; 2007 May; 102(2):225-8. PubMed ID: 17426890 [TBL] [Abstract][Full Text] [Related]
14. On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine. Costa G; Aguiar BG; Coelho PM; Cunha-Melo JR Acta Trop; 2003 Dec; 89(1):13-6. PubMed ID: 14636977 [TBL] [Abstract][Full Text] [Related]
15. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. Stelma FF; Sall S; Daff B; Sow S; Niang M; Gryseels B J Infect Dis; 1997 Jul; 176(1):304-7. PubMed ID: 9207389 [TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni: chemotherapy of infections of different ages. Sabah AA; Fletcher C; Webbe G; Doenhoff MJ Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice. Amin AM; Mikhail EG J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251 [TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni: permanence of modulation of the granulomatous inflammatory response in mice cured in the chronic phase. Coelho PM; Toppa NH; Feldmann JS; Gonçalves R; Mello RT Int J Parasitol; 1996 Dec; 26(12):1393-5. PubMed ID: 9024890 [TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates. Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238 [TBL] [Abstract][Full Text] [Related]
20. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured]. Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]